Short-term hypoxia promotes vascularization in co-culture system consisting of primary human osteoblasts and outgrowth endothelial cells.


Journal

Journal of biomedical materials research. Part A
ISSN: 1552-4965
Titre abrégé: J Biomed Mater Res A
Pays: United States
ID NLM: 101234237

Informations de publication

Date de publication:
01 2020
Historique:
received: 05 06 2019
revised: 08 08 2019
accepted: 12 08 2019
pubmed: 21 8 2019
medline: 10 6 2021
entrez: 21 8 2019
Statut: ppublish

Résumé

Prevascularization of tissue constructs before implantation has been developed as a novel and promising concept for successful implantation. Since hypoxia might induce angiogenesis, we have investigated the effects of hypoxic treatment on vascularization by using co-cultures of primary human osteoblasts (POBs) and outgrowth endothelial cells. Our results show that: (a) repeated short-term hypoxia (2% O

Identifiants

pubmed: 31430039
doi: 10.1002/jbm.a.36786
doi:

Substances chimiques

Inflammation Mediators 0
RNA, Messenger 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7-18

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Abaci, H. E., Truitt, R., Luong, E., Drazer, G., & Gerecht, S. (2010). Adaptation to oxygen deprivation in cultures of human pluripotent stem cells, endothelial progenitor cells, and umbilical vein endothelial cells. American Journal of Physiology. Cell Physiology, 298, C1527-C1537.
Amini, A. R., Laurencin, C. T., & Nukavarapu, S. P. (2012). Bone tissue engineering: Recent advances and challenges. Critical Reviews in Biomedical Engineering, 40, 363-408.
An, X., Jin, Y., Guo, H., Foo, S. Y., Cully, B. L., Wu, J., … Li, J. (2009). Response gene to complement 32 a novel hypoxia-regulated angiogenic inhibitor. Circulation, 120, 617-627.
Balguid, A., Mol, A., van Vlimmeren, M. A., Baaijens, F. P., & Bouten, C. V. (2009). Hypoxia induces near-native mechanical properties in engineered heart valve tissue. Circulation, 119, 290-297.
Befani, C., & Liakos, P. (2018). The role of hypoxia-inducible factor-2 alpha in angiogenesis. Journal of Cellular Physiology, 233, 9087-9098.
Bhaskar, B., Owen, R., Bahmaee, H., Rao, P. S., & Reilly, G. C. (2018). Design and assessment of a dynamic perfusion bioreactor for large bone tissue engineering scaffolds. Applied Biochemistry and Biotechnology, 185, 555-563.
Birkenhauer, E., & Neethirajan, S. (2015). A double-edged sword: The role of VEGF in wound repair and chemoattraction of opportunist pathogens. International Journal of Molecular Sciences, 16, 7159-7172.
Bland, E., Dréau, D., & Burg, K. J. (2013). Overcoming hypoxia to improve tissue-engineering approaches to regenerative medicine. Journal of Tissue Engineering and Regenerative Medicine, 7, 505-514.
Carreau, A., El Hafny-Rahbi, B., Matejuk, A., Grillon, C., & Kieda, C. (2011). Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia. Journal of Cellular and Molecular Medicine, 15, 1239-1253.
Chen, F. M., & Liu, X. (2016). Advancing biomaterials of human origin for tissue engineering. Progress in Polymer Science, 53, 86-168.
Ding, H., Chen, S., Yin, J. H., Xie, X. T., Zhu, Z. H., Gao, Y. S., & Zhang, C. Q. (2014). Continuous hypoxia regulates the osteogenic potential of mesenchymal stem cells in a time-dependent manner. Molecular Medicine Reports, 10, 2184-2190.
Dohle, E., El Bagdadi, K., Sader, R., Choukroun, J., James Kirkpatrick, C., & Ghanaati, S. (2018). Platelet-rich fibrin-based matrices to improve angiogenesis in an in vitro co-culture model for bone tissue engineering. Journal of Tissue Engineering and Regenerative Medicine, 12, 598-610.
Drager, J., Harvey, E. J., & Barralet, J. (2015). Hypoxia signalling manipulation for bone regeneration. Expert Reviews in Molecular Medicine, 17, e6.
Dzobo, K., Thomford, N. E., Senthebane, D. A., Shipanga, H., Rowe, A., Dandara, C., … Motaung, K. S. C. M. (2018). Advances in regenerative medicine and tissue engineering: Innovation and transformation of medicine. Stem Cells International, 2018, 2495848.
Farhang Ghahremani, M., Goossens, S., Nittner, D., Bisteau, X., Bartunkova, S., Zwolinska, A., … Haigh, J. J. (2013). p53 promotes VEGF expression and angiogenesis in the absence of an intact p21-Rb pathway. Cell Death and Differentiation, 20, 888-897.
Folkman, J. (2006). Tumor suppression by p53 is mediated in part by the antiangiogenic activity of endostatin and tumstatin. Science's STKE, 2006, pe35.
Fuchs, S., Motta, A., Migliaresi, C., & Kirkpatrick, C. J. (2006). Outgrowth endothelial cells isolated and expanded from human peripheral blood progenitor cells as a potential source of autologous cells for endothelialization of silk fibroin biomaterials. Biomaterials, 27, 5399-5408.
Gawlitta, D., Fledderus, J. O., van Rijen, M. H., Dokter, I., Alblas, J., Verhaar, M. C., & Dhert, W. J. (2012). Hypoxia impedes vasculogenesis of in vitro engineered bone. Tissue Engineering. Part A, 18, 208-218.
Gerhardt, H. (2008). VEGF and endothelial guidance in angiogenic sprouting. Organogenesis, 4, 241-246.
Grounds, M. D. (2018). Obstacles and challenges for tissue engineering and regenerative medicine: Australian nuances. Clinical and Experimental Pharmacology & Physiology, 45, 390-400.
Guo, D., Wang, Q., Li, C., Wang, Y., & Chen, X. (2017). VEGF stimulated the angiogenesis by promoting the mitochondrial functions. Oncotarget, 8, 77020-77027.
Hadjipanayi, E., & Schilling, A. F. (2013). Hypoxia-based strategies for angiogenic induction: The dawn of a new era for ischemia therapy and tissue regeneration. Organogenesis, 9, 261-272.
Heidemann, J., Ogawa, H., Dwinell, M. B., Rafiee, P., Maaser, C., Gockel, H. R., … Binion, D. G. (2003). Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. The Journal of Biological Chemistry, 278, 8508-8515.
Hu, K., & Olse, B. R. (2016). Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair. The Journal of Clinical Investigation, 126, 509-526.
Iruela-Arispe, M. L., & Davis, G. E. (2009). Cellular and molecular mechanisms of vascular lumen formation. Developmental Cell, 16, 222-231.
Jacobo, S. M., & Kazlauskas, A. (2015). Insulin-like growth factor 1 (IGF-1) stabilizes nascent blood vessels. The Journal of Biological Chemistry, 290, 6349-6360.
Kastenhuber, E. R., & Lowe, S. W. (2017). Putting p53 in context. Cell, 170, 1062-1078.
Koay, E. J., & Athanasiou, K. A. (2008). Hypoxic chondrogenic differentiation of human embryonic stem cells enhances cartilage protein synthesis and biomechanical functionality. Osteoarthritis and Cartilage, 16, 1450-1456.
Krock, B. L., Skuli, N., & Simon, M. C. (2011). Hypoxia-induced angiogenesis: Good and evil. Genes & Cancer, 2, 1117-1133.
Kuss, M. A., Wu, S., Wang, Y., Untrauer, J. B., Li, W., Lim, J. Y., & Duan, B. (2018). Prevascularization of 3D printed bone scaffolds by bioactive hydrogels and cell co-culture. Journal of Biomedical Materials Research. Part B, Applied Biomaterials, 106, 1788-1798.
Laschke, M. W., & Menger, M. D. (2012). Vascularization in tissue engineering: Angiogenesis versus inosculation. European Surgical Research, 48, 85-92.
Laschke, M. W., & Menger, M. D. (2016). Prevascularization in tissue engineering: Current concepts and future directions. Biotechnology Advances, 34, 112-121.
Li, A., Dubey, S., Varney, M. L., Dave, B. J., & Singh, R. K. (2003). IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. Journal of Immunology, 170, 3369-3376.
Li, M., Fuchs, S., Böse, T., Schmidt, H., Hofmann, A., Tonak, M., … Kirkpatrick, C. J. (2014). Mild heat stress enhances angiogenesis in a co-culture system consisting of primary human osteoblasts and outgrowth endothelial cells. Tissue Engineering. Part C, Methods, 20, 328-339.
Lin, S., Zhang, Q., Shao, X., Zhang, T., Xue, C., Shi, S., … Lin, Y. (2017). IGF-1 promotes angiogenesis in endothelial cells/adipose-derived stem cells co-culture system with activation of PI3K/Akt signal pathway. Cell Proliferation, 50(6), e12390.
Liu, Z. J., Shirakawa, T., Li, Y., Soma, A., Oka, M., Dotto, G. P., … Herlyn, M. (2003). Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: Implications for modulating arteriogenesis and angiogenesis. Molecular and Cellular Biology, 23, 14-25.
Lobov, I. B., Cheung, E., Wudali, R., Cao, J., Halasz, G., Wei, Y., … Wiegand, S. J. (2011). The Dll4/Notch pathway controls postangiogenic blood vessel remodeling and regression by modulating vasoconstriction and blood flow. Blood, 117, 6728-6737.
Lobov, I. B., Renard, R. A., Papadopoulos, N., Gale, N. W., Thurston, G., Yancopoulos, G. D., & Wiegand, S. J. (2007). Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proceedings of the National Academy of Sciences of the United States of America, 104, 3219-3224.
Logue, O. C., McGowan, J. W., George, E. M., & 3rd Bidwell, G. L. (2016). Therapeutic angiogenesis by vascular endothelial growth factor supplementation for treatment of renal disease. Current Opinion in Nephrology and Hypertension, 25, 404-409.
Ma, B., Dohle, E., Li, M., & Kirkpatrick, C. J. (2017). TLR4 stimulation by LPS enhances angiogenesis in a co-culture system consisting of primary human osteoblasts and outgrowth endothelial cells. Journal of Tissue Engineering and Regenerative Medicine, 11, 1779-1791.
Makris, E. A., Hu, J. C., & Athanasiou, K. A. (2013). Hypoxia-induced collagen crosslinking as a mechanism for enhancing mechanical properties of engineered articular cartilage. Osteoarthritis and Cartilage, 21, 634-641.
Malda, J., Klein, T. J., & Upton, Z. (2007). The roles of hypoxia in the in vitro engineering of tissues. Tissue Engineering, 13, 2153-2162.
Marsch, E., Sluimer, J. C., & Daemen, M. J. (2013). Hypoxia in atherosclerosis and inflammation. Current Opinion in Lipidology, 24, 393-400.
Messmer-Blust, A., An, X., & Li, J. (2009). Hypoxia-regulated angiogenic inhibitors. Trends in Cardiovascular Medicine, 19, 252-256.
Nauta, T. D., van Hinsbergh, V. W., & Koolwijk, P. (2014). Hypoxic signaling during tissue repair and regenerative medicine. International Journal of Molecular Sciences, 15, 19791-19815.
Noman, M. Z., Hasmim, M., Messai, Y., Terry, S., Kieda, C., Janji, B., & Chouaib, S. (2015). Hypoxia: A key player in antitumor immune response. A review in the theme: Cellular responses to hypoxia. American Journal of Physiology. Cell Physiology, 309, C569-C579.
Peng, W. X., Xiong, E. M., Ge, L., Wan, Y. Y., Zhang, C. L., Du, F. Y., … Gong, A. H. (2016). Egr-1 promotes hypoxia-induced autophagy to enhance chemo-resistance of hepatocellular carcinoma cells. Experimental Cell Research, 340, 62-70.
Rouwkema, J., & Khademhosseini, A. (2016). Vascularization and angiogenesis in tissue engineering: Beyond creating static networks. Trends in Biotechnology, 34, 733-745.
Schaffer, K., & Taylor, C. T. (2015). The impact of hypoxia on bacterial infection. The FEBS Journal, 282, 2260-2266.
Selden, C., & Fuller, B. (2018). Role of bioreactor technology in tissue engineering for clinical use and therapeutic target design. Bioengineering (Basel), 5(2), 32.
Semenza, G. L. (2014). Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annual Review of Pathology, 9, 47-71.
Sheng, J., Liu, D., Kang, X., Chen, Y., Jiang, K., & Zheng, W. (2018). Egr-1 increases angiogenesis in cartilage via binding Netrin-1 receptor DCC promoter. Journal of Orthopaedic Surgery and Research, 13, 125.
Shimoyamada, H., Yazawa, T., Sato, H., Okudela, K., Ishii, J., Sakaeda, M., … Kitamura, H. (2010). Early growth response-1 induces and enhances vascular endothelial growth factor-A expression in lung cancer cells. The American Journal of Pathology, 177, 70-83.
Slomiany, M. G., & Rosenzweig, S. A. (2006). Hypoxia-inducible factor-1-dependent and -independent regulation of insulin-like growth factor-1-stimulated vascular endothelial growth factor secretion. The Journal of Pharmacology and Experimental Therapeutics, 318, 666-675.
Teodoro, J. G., Evan, S. K., & Green, M. R. (2007). Inhibition of tumor angiogenesis by p53: A new role for the guardian of the genome. Journal of Molecular Medicine (Berlin, Germany), 85, 1175-1186.
Thangarajah, H., Vial, I. N., Chang, E., El-Ftesi, S., Januszyk, M., Chang, E. I., … Gurtner, G. C. (2009). IFATS collection: Adipose stromal cells adopt a proangiogenic phenotype under the influence of hypoxia. Stem Cells, 27, 266-274.
Unger, R. E., Dohle, E., & Kirkpatrick, C. J. (2015). Improving vascularization of engineered bone through the generation of pro-angiogenic effects in co-culture systems. Advanced Drug Delivery Reviews, 94, 116-125.
Walia, A., Yang, J. F., Huang, Y. H., Rosenblatt, M. I., Chang, J. H., & Azar, D. T. (2015). Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications. Biochimica et Biophysica Acta, 1850, 2422-2438.
Wang, W., Wang, Y., Deng, G., Ma, J., Huang, X., Yu, J., … Ye, X. (2018). Transplantation of hypoxic-preconditioned bone mesenchymal stem cells retards intervertebral disc degeneration via enhancing implanted cell survival and migration in rats. Stem Cells International, 2018, 1-13.

Auteurs

Bin Ma (B)

Institute of Pathology, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany.
Medical, Molecular and Forensic Sciences, Murdoch University, Murdoch, Western Australia, Australia.

Ming Li (M)

Institute of Pathology, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany.

Sabine Fuchs (S)

Institute of Pathology, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany.
Experimental Trauma Surgery, University Medical Center Schleswig-Holstein Kiel, Kiel, Germany.

Iris Bischoff (I)

Institute of Pathology, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany.

Alexander Hofmann (A)

Department of Trauma Surgery, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany.

Ronald E Unger (RE)

Institute of Pathology, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany.

Charles J Kirkpatrick (CJ)

Institute of Pathology, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH